-
DATA IDENTIFICATION
-
-
Name
-
Hepatitis B incidence per 100
-
Indicator purpose
-
Share of population who have been diagnosed with Hepatitis B
-
Abstract
-
The number of acute hepatitis B cases that are reported per 100,000 population in a given year by sex, age group, and race or ethnicity.
-
Data source
-
Ministry of Health
-
DATA CHARACTERISTICS
-
-
Contact organization person
-
Ministry of Health
-
Date last updated
-
12-SEP-2019
-
Periodicity
-
Annual
-
Unit of measure
-
Percentage (%)
-
Other characteristics
-
In March 2015, WHO launched its first "Guidelines for the prevention, care and treatment of persons living with chronic hepatitis B infection". The recommendations include:
- promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment;
- prioritize treatment for those with the most advanced liver disease and at greatest risk of mortality; and
- recommend the preferred use of the nucleos(t)ide analogues with a high barrier to drug resistance (tenofovir and entecavir, and entecavir in children aged 2–11 years) for first- and second-line treatment.
-
DATA CONCEPTS and CLASSIFICATIONS
-
-
Classification used
-
Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. Hepatitis B is also spread by needlestick injury, tattooing, piercing and exposure to infected blood and body fluids, such as saliva and, menstrual, vaginal, and seminal fluids. Sexual transmission of hepatitis B may occur, particularly in unvaccinated men who have sex with men and heterosexual persons with multiple sex partners or contact with sex workers.
-
Disaggregation
-
by country.
-
Key statistical concepts
-
This indicator is calculated using the following formula:

-
Formula
-
-
-
OTHER ASPECTS
-
-
Recommended uses
-
The Ministry of Health should create or effectively scale-up existing interventions, which include early treatment of Hepatitis B cases.
-
Limitations
-
N/A
-
Other comments
-
All the metadata shown in this document was gathered from United Nation Statistics Division. The metadata was extracted from https://unstats.un.org/sdgs/metadata/.